Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$972M |
| 2 |
Meta Platforms (Facebook)
META
|
+$324M |
| 3 |
Webster Financial
WBS
|
+$279M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Advanced Micro Devices
AMD
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
STL
Sterling Bancorp
STL
|
+$283M |
| 4 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$252M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.89% |
| 2 | Technology | 16.14% |
| 3 | Industrials | 12.35% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
First Business Financial Services
FBIZ
$587M
| $15.6M | ﹤0.01% |
475,540
+10,374
| +2% | +$335K |
|
|
MRTX
2102
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.6M | ﹤0.01% |
189,529
+104,215
| +122% | +$10.7M |
|
2103
Clarus
CLAR
$123M
| $15.5M | ﹤0.01% |
682,042
+35,333
| +5% | +$818K |
|
2104
Acadia Pharmaceuticals
ACAD
$4.43B
| $15.5M | ﹤0.01% |
641,223
-19,029
| -3% | -$460K |
|
2105
Independent Bank Corp
IBCP
$787M
| $15.5M | ﹤0.01% |
705,310
+59,782
| +9% | +$1.44M |
|
2106
Farmers National Banc Corp
FMNB
$939M
| $15.5M | ﹤0.01% |
909,240
+391
| +0% | +$6.97K |
|
2107
Beazer Homes USA
BZH
$877M
| $15.4M | ﹤0.01% |
1,013,201
+5,052
| +0.5% | +$89.7K |
|
2108
Sanofi
SNY
$103B
| $15.4M | ﹤0.01% |
300,009
+1,391
| +0.5% | +$71.8K |
|
|
PETQ
2109
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $15.4M | ﹤0.01% |
631,142
+94,759
| +18% | +$1.99M |
|
2110
Syndax Pharmaceuticals
SNDX
$1.69B
| $15.4M | ﹤0.01% |
884,334
+90,634
| +11% | +$1.53M |
|
2111
Construction Partners
ROAD
$5.84B
| $15.3M | ﹤0.01% |
585,455
+52,860
| +10% | +$1.39M |
|
2112
BCB Bancorp
BCBP
$173M
| $15.3M | ﹤0.01% |
839,823
+27,577
| +3% | +$482K |
|
|
TEN
2113
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $15.3M | ﹤0.01% |
836,106
+46,577
| +6% | +$668K |
|
|
RAD
2114
DELISTED
Rite Aid Corporation
RAD
| $15.3M | ﹤0.01% |
1,750,144
+733,923
| +72% | +$7.68M |
|
2115
Par Pacific Holdings
PARR
$4.31B
| $15.2M | ﹤0.01% |
1,170,057
+87,950
| +8% | +$1.25M |
|
2116
Aspen Aerogels
ASPN
$384M
| $15.2M | ﹤0.01% |
441,247
+21,112
| +5% | +$685K |
|
2117
Fate Therapeutics
FATE
$286M
| $15.1M | ﹤0.01% |
389,116
-25,361
| -6% | -$982K |
|
|
EGRX
2118
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $15.1M | ﹤0.01% |
304,784
+15,055
| +5% | +$723K |
|
2119
Pitney Bowes
PBI
$2.4B
| $15.1M | ﹤0.01% |
2,898,030
+115,108
| +4% | +$624K |
|
2120
CRISPR Therapeutics
CRSP
$4.73B
| $15.1M | ﹤0.01% |
239,987
-19,054
| -7% | -$1.2M |
|
|
VISN
2121
Vistance Networks Inc
VISN
$2.65B
| $15.1M | ﹤0.01% |
1,909,861
+78,555
| +4% | +$719K |
|
|
DOCU
2122
DocuSign
DOCU
$10.5B
| $15M | ﹤0.01% |
140,185
-1,809
| -1% | -$208K |
|
|
INN
2123
Summit Hotel Properties
INN
$746M
| $14.9M | ﹤0.01% |
1,495,898
-54,998
| -4% | -$540K |
|
2124
Powell Industries
POWL
$7.6B
| $14.9M | ﹤0.01% |
2,299,242
-97,524
| -4% | -$797K |
|
2125
OrthoPediatrics
KIDS
$519M
| $14.9M | ﹤0.01% |
275,186
+17,631
| +7% | +$901K |
|
Similar funds
Dimensional Fund Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Dimensional Fund Advisors held 3,635 positions worth $325B, down 1.9% from $331B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2022 filing shows 98 new, 2,062 increased, 1,167 reduced and 121 closed positions. Its largest new stake was Shell: 18,315,111 shares worth $1.01B. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $780M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2022 buy was Shell: 18,315,111 shares worth $1.01B.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q1 2022, an estimated $324M increase.
- Dimensional Fund Advisors's biggest Q1 2022 reduction was Canadian Pacific Kansas City, cutting an estimated $241M.
- Dimensional Fund Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $780M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $325B portfolio in Q1 2022.
- Dimensional Fund Advisors opened 98 new positions and closed 121 in Q1 2022.
- Dimensional Fund Advisors's portfolio value fell 1.9% quarter-over-quarter to $325B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.